🟢 NeOnc Technologies Holdings is trading 6.02% up with no clear company-specific catalyst

NeOnc Technologies Holdings is trading at $2.99, up 6.02%, with no clear company-specific catalyst identified for October 27.

• The October 26 announcement described plans for a proposed 500-patient international trial, not a completed trial or enrollment milestone.
• Biotech sector strength may be supporting the move: XBI is up 2.18% during the regular session, but the available context does not establish a direct cause for the stock’s gain.